FDA Inspection
Carter BloodCare - BaylorCarter BloodCare - Baylor – FDA Inspection, Jul 25, 2019
Record Details
This FDA Inspection record concerns Carter BloodCare - Baylor, with an inspection on July 25, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 8c27a9f0-557c-400c-9909-7ccb807c1d1b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1098356
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 606.160(b)Required records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Carter BloodCare - Baylor
6| Date | Classification | Office | Project area |
|---|---|---|---|
| April 26, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 6, 2017 | Not classified | Dallas District Office | |
| May 20, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 7, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 8, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Carter BloodCare - Baylor
- FDA Inspection 1237401 - 2024-04-26
- FDA Inspection 997964 - 2017-01-06
- FDA Inspection 927574 - 2015-05-20
- FDA Inspection 818049 - 2013-02-07
- FDA Inspection 733844 - 2011-07-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.